Stockscreener 앱 받기
0.135
87.50%
0.063
Prophase Labs Inc 주식(PRPH)의 최신 뉴스
MSN Money - MSN
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ProPhase Labs earnings missed by $2.47, revenue fell short of estimates - Investing.com Canada
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform - The Manila Times
Geopolitics Watch: What analysts say about ProPhase Labs Inc stock2026 Gainers & Target Return Focused Stock Picks - baoquankhu1.vn
ETF Watch: Is ProPhase Labs Inc exposed to political riskMarket Movement Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
Street Watch: Is ProPhase Labs Inc exposed to currency risksRate Cut & Daily Profit Focused Stock Screening - baoquankhu1.vn
Prophase Labs Stock Price Forecast. Should You Buy PRPH? - StockInvest.us
Earnings Update: How much upside does ProPhase Labs Inc have2026 Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Will ProPhase Labs Inc outperform the market in YEARTrade Performance Summary & Safe Entry Point Alerts - baoquankhu1.vn
Nasdaq Moves: Will ProPhase Labs Inc benefit from AI trends2026 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Market Review: Whats next for ProPhase Labs Inc stock2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
ProPhase Labs (NASDAQ:PRPH) versus Medicure (OTCMKTS:MCUJF) Financial Contrast - Defense World
ProPhase Labs, Inc. (PRPH) stock price, news, quote and history - Yahoo Finance UK
Risk Hedge: Is ProPhase Labs Inc exposed to political risk2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
Quarterly Risk: How does ProPhase Labs Inc score in quality rankings2026 Trading Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
ProPhase Labs Delays Annual 10-K Yearly Filing - TipRanks
ProPhase Labs (PRPH) notifies SEC of delayed FY2025 10-K; expects 15-day filing - Stock Titan
Guidance Update: Is ProPhase Labs Inc exposed to political risk2026 Snapshot & Weekly High Return Opportunities - baoquankhu1.vn
Trend Recap: What analysts say about ProPhase Labs Inc stockIndex Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Investment Recap: How much upside does ProPhase Labs Inc have2026 Macro Impact & Verified Entry Point Detection - baoquankhu1.vn
Gains Report: What analysts say about ProPhase Labs Inc stockQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
ProPhase Labs (PRPH) Updates on Crown Medical Collections Progre - GuruFocus
ProPhase Labs provides business update highlighting advancing Crown Medical collections activity - marketscreener.com
ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity - The Manila Times
Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity - TradingView
Biotech seeks insurer recoveries from 250+ payors for receivables-backed cash - Stock Titan
Big Picture: What analysts say about ProPhase Labs Inc stockQuarterly Growth Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Financial Analysis: ProPhase Labs (NASDAQ:PRPH) versus Ono Pharmaceutical (OTCMKTS:OPHLF) - Defense World
Aug Swings: How correlated is ProPhase Labs Inc to the S P500Earnings Overview Summary & Verified Short-Term Plans - baoquankhu1.vn
Short Covering: What analysts say about ProPhase Labs Inc stockVolume Spike & Long-Term Investment Growth Plans - baoquankhu1.vn
Guidance Update: Whats next for ProPhase Labs Inc stockJuly 2025 Final Week & Precise Buy Zone Identification - baoquankhu1.vn
Head-To-Head Review: ProPhase Labs (NASDAQ:PRPH) & Enliven Therapeutics (NASDAQ:ELVN) - Defense World
PRPH SEC FilingsProphase Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Advanced Biological Laboratories S.A. cancelled the acquisition of ProPhase Labs, Inc. in a reverse merger transaction. - marketscreener.com
ProPhase Labs Hosts Investor Webinar on Growth Portfolio - TipRanks
ProPhase Labs Initiates Potential Sale or Strategic - GlobeNewswire
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd - GlobeNewswire
ProPhase Labs Issues Update on Crown Medical Collections - TipRanks
ProPhase Labs (PRPH) Provides Update on COVID-19 Receivables Col - GuruFocus
ProPhase chases $50M from insurers as 50 COVID test claims near deals - Stock Titan
ProPhase Labs Secures Funding and Completes Market Transition Following Reverse Stock Split - AD HOC NEWS
ProPhase Labs enters $10 million equity line agreement with Generating Alpha - Investing.com
Off the Pink Sheets: ProPhase Labs shifts to OTC market - Stock Titan
Prophase Labs Approves Strategic Proposals at Special Meeting - MSN
ProPhase Labs, Inc.Common Stock (NQ: PRPH - FinancialContent
ProPhase Labs Updates Shareholders Amid Volatility and OTC Move - TipRanks
ProPhase Labs Announces Immediate Resignation of Board Member - TipRanks
ProPhase Labs Announces Board Resignation - TradingView — Track All Markets
Is ProPhase Labs Inc. stock a safe haven asset2025 Pullback Review & Weekly Watchlist of Top Performers - ulpravda.ru
How ProPhase Labs Inc. stock compares to market leadersCEO Change & Low Drawdown Trading Techniques - ulpravda.ru
How strong is ProPhase Labs Inc. stock balance sheetLayoff News & Community Verified Trade Signals - ulpravda.ru
Will ProPhase Labs Inc. stock outperform Nasdaq indexEarnings Overview Report & AI Driven Stock Reports - ulpravda.ru
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Total liabilities of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Cash from investing activities of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
ProPhase Labs faces NASDAQ delisting, plans appeal, OTC move - MSN
ProPhase Labs, Inc.(NasdaqCM: PRPH) dropped from S&P TMI Index - marketscreener.com
ProPhase Labs, Inc. Balance Sheet – OTC:PRPH - TradingView — Track All Markets
Free cash flow per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Long term debt to total assets ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Net margin % of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Price to cash flow ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Debt to equity ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Enterprise value to EBITDA ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
0.37%
0.54%
자본화:
|
볼륨(24시간):